Cyclops Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Srinagar, Jammu & Kashmir, India, established in 2012.
2012 Srinagar, Jammu & Kashmir, India Struck Off
Last Updated:
Access Report
About Cyclops Pharma Private Limited

Cyclops Pharma Private Limited, a struck off private limited company, was established on 28 December 2012 in Srinagar, Jammu & Kashmir, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24110JK2012PTC003762. Registered under ROC Roc Jammu. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Tariq Ahmad Sheikh (Director), Mohd Sadiq Wani (Managing Director). Past directors included Jagmohan Singh. Its latest AGM occurred on 23 December 2014, with the balance sheet filed on 31 March 2014. It is based at Sector B Bemina Abu Bakar Lane 1 Hamdania Colony Unity Education, Srinagar, Jammu & Kashmir, 190019.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24110JK2012PTC003762

  • Registration Number

    003762

  • Incorporation Date

    28 December 2012

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Jammu

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 1 Month
  • Last Filing with ROC 31 Mar 2014
Company report

Cyclops Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Cyclops Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Cyclops Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Tariq Ahmad Sheikh Director 28 Dec 2012 Current
Mohd Sadiq Wani Managing Director 28 Dec 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 20 Aug 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cyclops Pharma.

Enhance accessibility to Cyclops Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Cyclops Pharma revenue growth over time
Cyclops Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Cyclops Pharma?

Unlock access to Cyclops Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Cyclops Pharma?

Unlock and access historical data on people associated with Cyclops Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cyclops Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cyclops Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Cyclops Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Cyclops Pharma Private Limited last Annual general meeting of members was held on 23 Dec 2014 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Cyclops Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Jammu. was completed.

  • Director Appointment

    The activity Tariq Ahmad Sheikh was appointed as a Director was appointed as a Director on 28 Dec 2012 & has been associated with this company since 13 years 1 month . was completed.

  • Director Appointment

    Progress on Mohd Sadiq Wani was appointed as a Managing Director was appointed as a Managing Director on 28 Dec 2012 & has been associated with this company since 13 years 1 month . was documented.

  • Company Incorporation

    Progress on Cyclops Pharma Private Limited was registered on 28 Dec 2012 with Roc Jammu & aged 13 years 1 month as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Cyclops Pharma Private Limited?

The CIN of Cyclops Pharma Private Limited is U24110JK2012PTC003762.

Where is Cyclops Pharma Private Limited headquartered?

Cyclops Pharma Private Limited is headquartered at Sector B Bemina Abu Bakar Lane 1 Hamdania Colony Unity Education, Srinagar, Jammu & Kashmir, 190019.

When was Cyclops Pharma Private Limited incorporated?

Cyclops Pharma Private Limited was incorporated on 28 December 2012.

Who are the current directors of Cyclops Pharma Private Limited?

The current directors of Cyclops Pharma Private Limited are

What is the primary industry of Cyclops Pharma Private Limited?

The primary industry of Cyclops Pharma Private Limited is Chemicals.

Is Cyclops Pharma Private Limited a listed company?

Cyclops Pharma Private Limited is unlisted.

What is the capital structure of Cyclops Pharma Private Limited?

The authorized capital of Cyclops Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available